Update in diffuse parenchymal lung disease 2011

doi:10.1164/rccm.201203-0509UP

Review

. 2012 Jul 1;186(1):24-9.

doi: 10.1164/rccm.201203-0509UP.

Update in diffuse parenchymal lung disease 2011

Tracy R Luckhardt¹, Joachim Müller-Quernheim, Victor J Thannickal

Affiliations

Affiliation

¹ Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Boulevard, Birmingham, AL 35294, USA. victor.thannickal@ccc.uab.edu

PMID: 22753686
PMCID: PMC5448648
DOI: 10.1164/rccm.201203-0509UP

Review

Update in diffuse parenchymal lung disease 2011

Tracy R Luckhardt et al. Am J Respir Crit Care Med. 2012.

. 2012 Jul 1;186(1):24-9.

doi: 10.1164/rccm.201203-0509UP.

Authors

Tracy R Luckhardt¹, Joachim Müller-Quernheim, Victor J Thannickal

Affiliation

¹ Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Boulevard, Birmingham, AL 35294, USA. victor.thannickal@ccc.uab.edu

PMID: 22753686
PMCID: PMC5448648
DOI: 10.1164/rccm.201203-0509UP

No abstract available

PubMed Disclaimer

Cited by

Spectrum of high-resolution computed tomography pattern in lungs in patients with connective tissue disorders.
Chaudhury M, Kishore EH, Lingam L, Panda AK. Chaudhury M, et al. Ann Afr Med. 2023 Jul-Sep;22(3):246-251. doi: 10.4103/aam.aam_157_21. Ann Afr Med. 2023. PMID: 37417009 Free PMC article.
A clinical study to monitor prescription patterns, clinical outcomes, and adverse drug reactions among patients of various interstitial lung diseases attending respiratory medicine outpatient department at tertiary care hospital in Northern India.
Hasan S, Verma A, Haque S, Asif F, Nath R, Kant S, Dixit RK. Hasan S, et al. Perspect Clin Res. 2024 Jul-Sep;15(3):141-146. doi: 10.4103/picr.picr_108_23. Epub 2024 Jul 4. Perspect Clin Res. 2024. PMID: 39140017 Free PMC article.
E-cigarette-/Vape-Associated Lung Injury as a Cause of Interstitial Lung Disease.
Vess KB, Ivan N, Boscia J. Vess KB, et al. Cureus. 2024 Apr 13;16(4):e58199. doi: 10.7759/cureus.58199. eCollection 2024 Apr. Cureus. 2024. PMID: 38741809 Free PMC article.
Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function.
Guo X, Qi J, Li H, Xing Z. Guo X, et al. Exp Ther Med. 2020 Aug;20(2):1285-1290. doi: 10.3892/etm.2020.8858. Epub 2020 Jun 10. Exp Ther Med. 2020. PMID: 32765668 Free PMC article.
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.
McKleroy W, Lee TH, Atabai K. McKleroy W, et al. Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L709-21. doi: 10.1152/ajplung.00418.2012. Epub 2013 Apr 5. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23564511 Free PMC article. Review.

References

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824. - PMC - PubMed
1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664. - PubMed
1. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, et al. . An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605–614. - PubMed
1. Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431–440. - PubMed
1. Noble PW, Richeldi L, Kaminski N. End of an era: lessons from negative clinical trials in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:4–5. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

K08 HL094666/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824. - PMC - PubMed

[2] Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824. - PMC - PubMed

[3] American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664. - PubMed

[4] American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664. - PubMed

[5] Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, et al. . An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605–614. - PubMed

[6] Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, et al. . An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605–614. - PubMed

[7] Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431–440. - PubMed

[8] Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431–440. - PubMed

[9] Noble PW, Richeldi L, Kaminski N. End of an era: lessons from negative clinical trials in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:4–5. - PubMed

[10] Noble PW, Richeldi L, Kaminski N. End of an era: lessons from negative clinical trials in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:4–5. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Update in diffuse parenchymal lung disease 2011

Affiliation

Update in diffuse parenchymal lung disease 2011

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical